SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Smith, S. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, S. M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The impact of hyperprolactinaemia on sexual function in patients with psychosis

Shubulade M Smith

Institute of Psychiatry at Kings College London, PO Box 23, Decrespigny Park, Camberwell, London, UK, s.smith{at}iop.kcl.ac.uk

Sexual dysfunction is a common but significantly underestimated side effect of antipsychotic medication. It is frequently related to the hyperprolactinaemia that can be induced by dopamine-blocking properties of these agents, but may also be related to the anti-serotonergic properties or anticholinergic and antiadrenergic properties of antipsychotics. Knowledge of the receptor pharmacology of an individual antipsychotic will help to determine whether it is more or less likely to cause sexual side effects.

Key Words: prolactin • sexual dysfunction • psychosis • antipsychotic • sex hormones

Journal of Psychopharmacology, Vol. 22, No. 2 suppl, 63-69 (2008)
DOI: 10.1177/0269881107088438
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
V. O'Keane
Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia
J Psychopharmacol, March 1, 2008; 22(2_suppl): 70 - 75.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
J. Walters and I. Jones
Clinical questions and uncertainty -- prolactin measurement in patients with schizophrenia and bipolar disorder
J Psychopharmacol, March 1, 2008; 22(2_suppl): 82 - 89.
[Abstract] [PDF]


Advertisement